Pages that link to "Q43797117"

The following pages link to Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care (Q43797117):

Displaying 25 items.

• Potentially severe drug-drug interactions among older people and associations in assisted living facilities in Finland: a cross-sectional study (Q28829102) (← links)
• Understanding and preventing drug-drug and drug-gene interactions (Q34415944) (← links)
• Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial (Q34511248) (← links)
• The continuing challenge of providing drug information services to diminish the knowledge--practice gap in medical practice (Q34703735) (← links)
• On the alert: future priorities for alerts in clinical decision support for computerized physician order entry identified from a European workshop (Q35003609) (← links)
• Drug-drug interactions and acute kidney injury: caveat prescriptor (Q35339955) (← links)
• A pilot study on the impact of known drug-drug interactions in cancer patients (Q35990349) (← links)
• Information Technology-Based Interventions to Improve Drug-Drug Interaction Outcomes: A Systematic Review on Features and Effects (Q36204754) (← links)
• Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study (Q36478233) (← links)
• Drug-drug interaction software in clinical practice: a systematic review (Q38295919) (← links)
• Co-Prescribing of Potentially Interacting Drugs during Warfarin Therapy - A Population-Based Register Study. (Q38417110) (← links)
• Educational intervention on medication reviews aiming to reduce acute healthcare consumption in elderly patients with potentially inappropriate medicines-A pragmatic open-label cluster-randomized controlled trial in primary care. (Q38629270) (← links)
• Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy (Q38722185) (← links)
• Clinical decision support systems differ in their ability to identify clinically relevant drug interactions of immunosuppressants in kidney transplant patients (Q38948671) (← links)
• Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study (Q39434611) (← links)
• A limited number of prescribed drugs account for the great majority of drug-drug interactions (Q44904056) (← links)
• A survey of attitudes, practices, and knowledge regarding drug-drug interactions among medical residents in Iran (Q47400987) (← links)
• High Prevalence of Drug-Drug Interactions in Primary Health Care is Caused by Prescriptions from other Healthcare Units (Q47588206) (← links)
• Drug Prescription Including Interactions with Anticancer Treatments in the Elderly: A Global Approach (Q51793495) (← links)
• Clinical pharmacology in Stockholm 50 years-report from the jubilee symposium. (Q55114510) (← links)
• Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment. (Q55363294) (← links)
• Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data. (Q64894930) (← links)
• Drug information centre queries and responses about drug interactions over 10 years-A descriptive analysis (Q91924155) (← links)
• Identification and ranking of important bio-elements in drug-drug interaction by Market Basket Analysis (Q94503598) (← links)
• eHealth technologies assisting in identifying potential adverse interactions with complementary and alternative medicine (CAM) or standalone CAM adverse events or side effects: a scoping review (Q98163633) (← links)